Atlas Trials

A Study to Determine the Safety and Efficacy of Oligopin® on Metabolic Risk Factors in Subjects With Metabolic Syndrome

Clinical trial NCT04488653 · UNKNOWN

Trial details

NCT number
NCT04488653
Sponsor
Les Derives Resiniques et Terpeniques
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Metabolic Syndrome
Start date
2020-06-24
Primary completion
2021-10-19
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.